K. Robert Shen, MD
Central Message.
Atrioesophageal fistula is a rare but highly lethal complication after catheter ablation for atrial fibrillation that thoracic surgeons will increasingly be asked to manage.
See Article page 167.
In this case report, Gibney and colleagues1 describe the successful management of an atrioesophageal fistula (AEF) that developed as a complication of previous percutaneous ablation for atrial fibrillation. This timely report addresses a rare but highly lethal clinical scenario that all thoracic surgeons will increasingly face in the future.
Catheter ablation has recently become a cornerstone of therapy for patients with paroxysmal and chronic atrial fibrillation. Recent large randomized trials, such as the CASTLE-AF and CABANA trials,2,3 demonstrating the benefits of catheter ablation for atrial fibrillation are expected to lead to an increased number of atrial fibrillation ablations performed worldwide.
As the authors have noted, because the development of AEF is a rare but highly lethal complication of catheter ablation for atrial fibrillation, early recognition of the complication and prompt surgical intervention is imperative. In literature reviews of all reported patients with AEF after catheter ablation for atrial fibrillation, fever and neurologic deficits were the most common presenting symptoms, and the 2012 Heart Rhythm Society consensus statement on catheter and surgical ablation of atrial fibrillation has highlighted these 2 symptoms.4
Other take-home messages:
-
1.
Chest and head CT scans seem to be the most useful and accurate diagnostic modality for identifying AEF.
-
2.
According to the Heart Rhythm Society, endoscopy should be avoided, because it could lead to massive air embolism with resulting stroke and possible death.4
-
3.
Interposition of healthy vascularized tissue between the repaired esophagus and atria is worthwhile to lower the risk of recurrent fistula.
-
4.
Preparations should be made to use cardiopulmonary bypass if necessary during the surgical repair of the AEF because, depending on the location of the fistula, the left atrium may need to be explored.
Footnotes
Disclosures: The author reported no conflicts of interest.
The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
References
- 1.Felmly L.M., Gibney B.C. Atrioesophageal fistula from percutaneous ablation for atrial fibrillation. J Thorac Cardiovasc Surg Tech. 2021;6:167–168. doi: 10.1016/j.xjtc.2020.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Marrouche N.F., Brachmann J., Andresen D., Siebels J., Boersma L., Jordaens L., CASTLE-AF Investigators Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–427. doi: 10.1056/NEJMoa1707855. [DOI] [PubMed] [Google Scholar]
- 3.Packer D.L., Mark D.B., Robb R.A., Monahan K.H., Bahnson T.D., Moretz K., CABANA Investigators Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation (CABANA) trial: study rationale and design. Am Heart J. 2018;199:192–199. doi: 10.1016/j.ahj.2018.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Calkins H., Kuck K.H., Cappato R. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528–606. doi: 10.1093/europace/eus027. [DOI] [PubMed] [Google Scholar]